Century Therapeutics (IPSC) Other Working Capital Changes (2020 - 2026)
Century Therapeutics (IPSC) posted quarterly Other Working Capital Changes of -$786000.0 for Q1 2026, up 31.89% year-over-year from -$595955.3 in Q1 2025, and up 43.82% quarter-over-quarter from -$1.4 million in Q4 2025.
Century Therapeutics (IPSC) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Other Working Capital Changes for 7 consecutive years, with -$786000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 31.89% year-over-year to -$786000.0; the TTM figure through Mar 2026 stood at -$4.6 million (down 97.6% YoY), while the FY2025 annual figure was -$5.0 million, down 47.93% from the prior year.
- Other Working Capital Changes advanced to -$786000.0 in Q1 2026 per IPSC's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $121.8 million in Q2 2022 and bottomed at -$120.3 million in Q3 2022.
- Historically, Other Working Capital Changes has averaged $479750.0 across 5 years, with a median of -$274000.0 in 2023.
- On a YoY basis, Other Working Capital Changes climbed as much as 52520.0% in 2022 and fell as far as 219.69% in 2022.
- Century Therapeutics' Other Working Capital Changes stood at $2.1 million in 2022, then climbed by 14.92% to $2.4 million in 2023, then slumped by 132.29% to -$766000.0 in 2024, then slumped by 82.64% to -$1.4 million in 2025, then surged by 43.82% to -$786000.0 in 2026.
- Business Quant data shows IPSC's Other Working Capital Changes at -$786000.0 in Q1 2026, -$1.4 million in Q4 2025, and -$1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16 Mn |
| Jun 30, 2026 | 1.16 Mn |
| Jun 30, 2026 | 1.16 Mn |
| Mar 31, 2026 | 62,000.00 |
| Mar 31, 2026 | 62,000.00 |
| Mar 31, 2026 | 62,000.00 |
| Sep 30, 2025 | -108.73 Mn |
| Sep 30, 2025 | -108.73 Mn |
| Sep 30, 2025 | -108.73 Mn |
| Jun 30, 2025 | -147,000.00 |
| Jun 30, 2025 | -147,000.00 |
| Jun 30, 2025 | -147,000.00 |
| Mar 31, 2025 | -289,000.00 |
| Mar 31, 2025 | -289,000.00 |
| Mar 31, 2025 | -289,000.00 |
| Dec 31, 2024 | 1.87 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Sep 30, 2024 | -4.54 Mn |
| Sep 30, 2024 | -4.54 Mn |